PCSK9, FROM GENE AND VARIANTS TO PROTEIN AND PHENOTYPE

被引：0
|
作者：
Abifadel, M. [1 ,2 ]
Bernier, L. [3 ]
Bonneau, J. [1 ]
Marques, A. [1 ]
Marduel, M. [1 ]
Devillers, M. [1 ]
Erlich, D. [1 ]
Rabes, J. -P. [1 ,4 ]
Varret, M. [1 ]
Davignon, J. [3 ]
Boileau, C. [1 ,4 ]
机构：
[1] Hop Necker Enfants Malad, INSERM, U781, F-75743 Paris, France
[2] Univ St Joseph, Fac Pharm, Beirut, Lebanon
[3] Inst Rech Clin Montreal, Montreal, PQ H2W 1R7, Canada
[4] CHU Ambroise Pare, Genet Mol, Biochim Lab, Bergen, Norway
来源：
ATHEROSCLEROSIS SUPPLEMENTS | 2008年 / 9卷 / 01期
关键词：
D O I：
10.1016/S1567-5688(08)70407-0
中图分类号：
R6 [外科学];
学科分类号：
1002 ; 100210 ;
摘要：
引用
收藏
页码：101 / 101
页数：1
相关论文
共 50 条
  • [11] Effects of PCSK9 Inhibition on Plasma PCSK9 Concentration and Hepatic PCSK9 Expression
    Shapiro, Michael D.
    Tavori, Hagai
    Oleaga, Carlota
    Miles, Joshua
    Fazio, Sergio
    ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2018, 38
  • [12] Association of PCSK9 Variants With the Risk of Atherosclerotic Cardiovascular Disease and Variable Responses to PCSK9 Inhibitor Therapy
    Krittanawong, Chayakrit
    Khawaja, Muzamil
    Rosenson, Robert S.
    Amos, Christopher, I
    Nambi, Vijay
    Lavie, Carl J.
    Virani, Salim S.
    CURRENT PROBLEMS IN CARDIOLOGY, 2022, 47 (07)
  • [13] Common and Low-Frequency Genetic Variants in the PCSK9 Locus Influence Circulating PCSK9 Levels
    Chernogubova, Ekaterina
    Strawbridge, Rona
    Mahdessian, Hovsep
    Malarstig, Anders
    Krapivner, Sergey
    Gigante, Bruna
    Hellenius, Mai-Lis
    de Faire, Ulf
    Franco-Cereceda, Anders
    Syvaenen, Ann-Christine
    Troutt, Jason S.
    Konrad, Robert J.
    Eriksson, Per
    Hamsten, Anders
    van 't Hooft, Ferdinand M.
    ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2012, 32 (06) : 1526 - +
  • [14] Genetics: HMGCR and PCSK9 variants and cardiovascular risk
    Lim G.B.
    Nature Reviews Cardiology, 2017, 14 (2) : 66 - 66
  • [15] PCSK9 in South African Variants of Familial Hypercholesterolemia
    Getz, Godfrey S.
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2014, 63 (22) : 2374 - 2375
  • [16] The PCSK9 gene: a new gene controlling cholesterolemia
    Cefalu, Angelo B.
    Amato, Salvatore
    Fertitta, Emanuela
    Fayer, Francesca
    Valenti, Vincenza
    Gueli, Maria C.
    Di Blasi, Ugo
    Pagano, Michele
    Nardi, Isa Bella
    Cusumano, Gaspare
    Gulotta, Paolo
    Raffa, Alessandro
    Doveri, Tiziana
    Averna, Maurizio R.
    ACTA MEDICA MEDITERRANEA, 2007, 23 (01): : 11 - 14
  • [17] DIFFERENTIAL CONTRIBUTION OF PCSK9 AND LPL GENE VARIANTS ON LIPID PROFILE IN THE GENERAL POPULATION
    Baragetti, Andrea
    Garlaschelli, Katia
    Grigore, Liliana
    Norata, Giuseppe Danilo
    Catapano, Alberico Luigi
    ATHEROSCLEROSIS, 2017, 263 : E66 - E66
  • [18] Degradation of the LDL receptors by PCSK9 is not mediated by a secreted protein acted upon by PCSK9 extracellularly
    Holla, Oystein L.
    Cameron, Jamie
    Berge, Knut Erik
    Ranheim, Trine
    Leren, Trond P.
    BMC CELL BIOLOGY, 2007, 8 (1)
  • [19] Degradation of the LDL receptors by PCSK9 is not mediated by a secreted protein acted upon by PCSK9 extracellularly
    Øystein L Holla
    Jamie Cameron
    Knut Erik Berge
    Trine Ranheim
    Trond P Leren
    BMC Cell Biology, 8
  • [20] Differential effects of PCSK9 loss of function variants on serum lipid and PCSK9 levels in Caucasian and African Canadian populations
    Janice Mayne
    Teik Chye Ooi
    Angela Raymond
    Marion Cousins
    Lise Bernier
    Thilina Dewpura
    Francine Sirois
    Majambu Mbikay
    Jean Davignon
    Michel Chrétien
    Lipids in Health and Disease, 12
12345